Agah Ramtin's Insider Trades & SAST Disclosures

Agah Ramtin's most recent trade in RenovoRx Inc was a trade of 40,983 Common Stock done . Disclosure was reported to the exchange on Jan. 26, 2024.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
RenovoRx Inc
Ramtin Agah Director, Chief Medical Officer Purchase of securities on an exchange or from another person at price $ 0.00 per share. 26 Jan 2024 40,983 47,460 - - Common Stock
RenovoRx Inc
Agah Ramtin Director, Chief Medical Officer Purchase of securities on an exchange or from another person at price $ 0.00 per share. 26 Jan 2024 40,983 40,983 - - Warrants
RenovoRx Inc
Agah Ramtin Director, Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Jan 2024 125,132 125,132 - - Stock Option
RenovoRx Inc
Agah Ramtin Director, Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Jan 2024 28,424 28,424 - - Stock Option
RenovoRx Inc
Ramtin Agah Director, Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Mar 2023 65,000 65,000 - - Employee Stock Option (right to buy)
RenovoRx Inc
Ramtin Agah Director, Chief Medical Officer, Ten Percent Owner Gift of securities by or to the insider at price $ 0.00 per share. 07 Jun 2022 975,000 1,295 - 0 Common Stock
RenovoRx Inc
Ramtin Agah Director, Chief Medical Officer, Ten Percent Owner Gift of securities by or to the insider at price $ 0.00 per share. 07 Jun 2022 975,000 975,000 - 0 Common Stock
RenovoRx Inc
Ramtin Agah Director, Chief Medical Officer, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 1.93 per share. 07 Jun 2022 5,182 6,477 - 1.9 10,001 Common Stock
RenovoRx Inc
Ramtin Agah Director, Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Mar 2022 21,398 21,398 - - Employee Stock Option (right to buy)
RenovoRx Inc
Ramtin Agah Director, Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Sep 2021 52,203 52,203 - - Employee Stock Option (right to buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades